Cityland Development (PHS:CDC) YoY EBITDA Growth: 230.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHS:CDC Cityland Development Corp PHS:CDC
49 GF Score
Price ₱0.61
GF Value ₱0.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Cityland Development YoY EBITDA Growth?

Cityland Development PHS:CDC +5.17% 49 YoY EBITDA Growth is 230.00% as of Mar. 2026. GuruFocus rates PHS:CDC with a GF Score™ of 49/100 and a GF Value™ of ₱0.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cityland Development's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 230.00%.

Cityland Development's EBITDA per Share for the three months ended in Mar. 2026 was ₱0.07.

Cityland Development YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Cityland Development's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cityland Development YoY EBITDA Growth Chart

Cityland Development Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.13 87.22 -22.26 -9.54 -10.97

Cityland Development Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.49 80.56 4.92 -28.42 230.00
PHS:CDC
49GF Score
Cityland Development Corp PHS:CDC
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cityland Development YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cityland Development's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.211-0.237)/ | 0.237 |
=-10.97 %

Cityland Development's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.066-0.02)/ | 0.02 |
=230.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 230.00% mean?
Cityland Development (PHS:CDC) has a YoY EBITDA Growth of 230.00% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cityland Development and its competitors.
Is Cityland Development's YoY EBITDA Growth too high?
Cityland Development's current YoY EBITDA Growth is 230.00%. Overall, Cityland Development has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cityland Development's YoY EBITDA Growth compare to CBRE and BEKE?
Cityland Development's YoY EBITDA Growth of 230.00% can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Real Estate company?
A good YoY EBITDA Growth depends on the Real Estate industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cityland Development and its competitors. Cityland Development's current YoY EBITDA Growth is 230.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cityland Development stock overvalued right now?
Based on GuruFocus' analysis, Cityland Development (PHS:CDC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₱0.74, compared to a current price of ₱0.61 — trading 17.6% below its estimated fair value. The current YoY EBITDA Growth is 230.00%. Cityland Development's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Cityland Development (PHS:CDC), the current YoY EBITDA Growth is 230.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cityland Development (PHS:CDC) Overvalued in 2026?

Based on GuruFocus' analysis, Cityland Development stock appears to be undervalued. The current stock price of ₱0.61 is trading 17.6% below its estimated GF Value™ of ₱0.74. GuruFocus considers Cityland Development to be Modestly Undervalued.

Key valuation signals for PHS:CDC:

  • YoY EBITDA Growth: 230.00%
  • GF Value™: ₱0.74 vs. price of ₱0.61 (17.6% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the PHS:CDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cityland Development Business Description

Address 156 H.V. Dela Costa Street, 3rd Floor, Cityland Condominium 10, Tower II, Makati, PHL, 1226
Cityland Development Corp operates as a real estate company that acquire, develop, improve, subdivide, cultivate, lease, sublease, sell, exchange, barter and/or dispose of agricultural, industrial, commercial, residential and other real properties, as well as to construct, improve, lease, sublease, sell and/or dispose of houses, buildings and other improvements thereon, and to manage and operate subdivisions and housing projects or otherwise engage in the financing and trading of real estate. Its operations are carried through the following segments: Sale of Real Estate Properties, Lease of Real Estate Properties, and Pension Plan Operations. The Company derives its revenues from the sale and lease of real estate properties and its investments in trust funds.
49GF Score

Get the complete analysis for PHS:CDC

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱0.61
Price
₱0.74
GF Value